��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title Impression of Clinical Worsening Fails To Predict Interferon-beta Neutralizing Antibody Status

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 161

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Jan A. Hillert, MD (Karolinska Institute, Neurology R54)	Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Hillert has received research support from Biogen. The institution of Dr. Hillert has received research support from Celgene. The institution of Dr. Hillert has received research support from Merck. The institution of Dr. Hillert has received research support from Novartis. The institution of Dr. Hillert has received research support from Sanofi. The institution of Dr. Hillert has received research support from Roche.
Erica McKenzie, MD (University of Calgary, Department of Clinical Neurosciences)	Dr. McKenzie has nothing to disclose.
Uros Rot, DO	No disclosure on file
Ajith Sominanda	No disclosure on file
	No disclosure on file